Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Other Non-Current Liabilities (2023 - 2025)

Bio Essence has reported Other Non-Current Liabilities over the past 3 years, most recently at $301959.0 for Q1 2025.

  • For Q1 2025, Other Non-Current Liabilities rose 438.32% year-over-year to $301959.0; the TTM value through Mar 2025 reached $301959.0, up 438.32%, while the annual FY2024 figure was $447414.0, 54.88% down from the prior year.
  • Other Non-Current Liabilities for Q1 2025 was $301959.0 at Bio Essence, down from $447414.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $991529.0 in Q4 2023 and troughed at $56093.0 in Q1 2024.
  • A 3-year average of $477505.4 and a median of $447414.0 in 2024 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: plummeted 54.88% in 2024 and later surged 438.32% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $991529.0 in 2023, then plummeted by 54.88% to $447414.0 in 2024, then crashed by 32.51% to $301959.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for BIOE at $301959.0 in Q1 2025, $447414.0 in Q4 2024, and $590532.0 in Q3 2024.